Most Recent Annual Report
2019 Annual Report and Form 10K
About AtriCure, Inc.
501-1000 Employees
Based in Mason, Ohio
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide.
- Ticker:
- ATRC
- Exchange:
- NASDAQ (See More NASDAQ Companies)
- Industry:
- Medical Instruments & Supplies (See More Medical Instruments & Supplies Companies)
- Sector:
- Healthcare (See More Healthcare Companies)
